Literature DB >> 15857389

Mutations in the neurofilament light gene linked to Charcot-Marie-Tooth disease cause defects in transport.

Raül Pérez-Ollé1, Miguel A López-Toledano, Dmitry Goryunov, Noemi Cabrera-Poch, Leonidas Stefanis, Kristy Brown, Ronald K H Liem.   

Abstract

Neurofilament light gene mutations have been linked to a subset of patients with Charcot-Marie-Tooth disease, the most common inherited motor and sensory neuropathy. We have previously shown that Charcot-Marie-Tooth-linked mutant neurofilament light assembles abnormally in non-neuronal cells. In this study, we have characterized the effects of expression of mutant neurofilament light proteins on axonal transport in a neuronal cell culture model. We demonstrated that the Charcot-Marie-Tooth-linked neurofilament light mutations: (i) affect the axonal transport of mutant neurofilaments; (ii) have a dominant-negative effect on the transport of wild-type neurofilaments; (iii) affect the transport of mitochondria and the anterograde axonal transport marker human amyloid precursor protein; (iv) result in alterations of retrograde axonal transport and (v) cause fragmentation of the Golgi apparatus. Increased neuritic degeneration was observed in neuronal cells overexpressing neurofilament light mutants. Our results suggest that these generalized axonal transport defects could be responsible for the neuropathy in Charcot-Marie-Tooth disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15857389     DOI: 10.1111/j.1471-4159.2005.03095.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  37 in total

1.  Axonal pathology precedes demyelination in a mouse model of X-linked demyelinating/type I Charcot-Marie Tooth neuropathy.

Authors:  Natalie Vavlitou; Irene Sargiannidou; Kyriaki Markoullis; Kyriacos Kyriacou; Steven S Scherer; Kleopas A Kleopa
Journal:  J Neuropathol Exp Neurol       Date:  2010-09       Impact factor: 3.685

2.  NEFL E396K mutation is associated with a novel dominant intermediate Charcot-Marie-Tooth disease phenotype.

Authors:  José Berciano; Antonio García; Kristien Peeters; Elena Gallardo; Els De Vriendt; Ana L Pelayo-Negro; Jon Infante; Albena Jordanova
Journal:  J Neurol       Date:  2015-04-01       Impact factor: 4.849

Review 3.  Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration.

Authors:  Rodolphe Perrot; Raphael Berges; Arnaud Bocquet; Joel Eyer
Journal:  Mol Neurobiol       Date:  2008-07-23       Impact factor: 5.590

4.  Neurofilaments bind tubulin and modulate its polymerization.

Authors:  Arnaud Bocquet; Raphael Berges; Ronald Frank; Patrick Robert; Alan C Peterson; Joël Eyer
Journal:  J Neurosci       Date:  2009-09-02       Impact factor: 6.167

Review 5.  Mitochondria: the next (neurode)generation.

Authors:  Eric A Schon; Serge Przedborski
Journal:  Neuron       Date:  2011-06-23       Impact factor: 17.173

6.  Tau45-230 association with the cytoskeleton and membrane-bound organelles: Functional implications in neurodegeneration.

Authors:  Sana Afreen; D Nicole Riherd Methner; Adriana Ferreira
Journal:  Neuroscience       Date:  2017-08-24       Impact factor: 3.590

7.  Mitochondrial membrane potential is regulated by vimentin intermediate filaments.

Authors:  Ivan S Chernoivanenko; Elena A Matveeva; Vladimir I Gelfand; Robert D Goldman; Alexander A Minin
Journal:  FASEB J       Date:  2014-11-17       Impact factor: 5.191

Review 8.  Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease.

Authors:  Axel Niemann; Philipp Berger; Ueli Suter
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 9.  Molecular genetics of autosomal-dominant axonal Charcot-Marie-Tooth disease.

Authors:  Stephan Züchner; Jeffery M Vance
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

10.  HDAC1 nuclear export induced by pathological conditions is essential for the onset of axonal damage.

Authors:  Jin Young Kim; Siming Shen; Karen Dietz; Ye He; Owain Howell; Richard Reynolds; Patrizia Casaccia
Journal:  Nat Neurosci       Date:  2009-12-27       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.